The study was conducted in accordance with the Declaration of Helsinki and approved by the University of Central Lancashire’s Ethics Committee (approval reference: STEMH 910 Phase 2. June 8, 2021). 
Informed consent was obtained from all subjects involved in the study.
An anonymized datasheet of the clinical and performance measures from this study is available on request.